膜性肌肉肉瘤中的分子标:进展和陷的叙述性审查
Barbara Ziemba1, Klaudia Lukow1
1Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., 90-236 Lodz, Poland.
International journal of molecular sciences
|June 13, 2025
概括
膜筋骨髓瘤 (ARMS) 是一种由融合蛋白驱动的儿科癌症. 本综述探讨了新的分子标和疗法,以改善融合阳性ARMS患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 儿科癌症研究儿童癌症研究
背景情况:
- 气囊性狂宫肌肉瘤 (ARMS) 是一种侵袭性的儿科软组织肉瘤.
- 融合蛋白,特别是PAX3/7-FOXO1,是ARMS的主要驱动因素.
- 目前的疗法对融合阳性ARMS患者提供有限的成功.
研究的目的:
- 审查ARMS分子病原学的最新进展.
- 确定ARMS的关键诊断和治疗目标.
- 为开发改进的,有针对性的治疗提供一个框架.
主要方法:
- 关于ARMS分子病原学的最新进展的文献综述.
- 对关键分子驱动因素,生物标志物和治疗点的分析.
- 评估新兴的治疗策略,包括免疫疗法和表观遗传修饰剂.
主要成果:
- PAX3/7-FOXO1融合蛋白通过重编程转录,损害分化和激活超级增强剂来驱动ARMS.
- 新兴的生物标志物包括YAP,TFAP2B和P-cadherin.
- 潜在的治疗点包括瘤性激酶 (Aurora A,CDK4,PLK1),受体氨酸激酶 (FGFR,MET) 和转录因子 (FOXF1,ETS1).
结论:
- 了解ARMS分子驱动因素对于治疗开发至关重要.
- 由生物标志物指导的多目标疗法为改善ARMS患者的治疗结果提供了希望.
- 对免疫疗法,表观遗传修饰剂和非编码RNA的进一步研究可能会产生新的治疗策略.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.3K
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
3.6K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
